We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Prone Biopsy System Offers 3D Imaging-Guided Breast Biopsy

By MedImaging International staff writers
Posted on 05 May 2016
Print article
Image: The Affirm prone biopsy system (Photo courtesy of Hologic).
Image: The Affirm prone biopsy system (Photo courtesy of Hologic).
A novel prone biopsy system allows radiologists to better target lesions found during three dimensional (3D) guided mammography exams, as well as other screening modalities.

The Hologic Affirm Prone Biopsy System combines minimally invasive, stereotactic breast biopsy with 3D guidance technology to provide true 360-degree access to lesions, with the aid of a fully integrated C-arm that rotates around the patient, who is lying in a prone position. As a result, approach angles can be varied with minimal movement on the patient's part, as she is supported throughout the procedure. The system also features a streamlined workflow with increased automation to raise patient satisfaction and eliminate a direct view of the biopsy needle.

The Affirm prone biopsy system, a product of Hologic (Bedford, MA, USA), is the first dedicated prone system to offer both 2D and 3D imaging-guided breast biopsies. The system also expands the company's breast biopsy portfolio, complementing the Genius 3D mammography exam and the Affirm upright biopsy system, and has been approved by the U.S. Food and Drug Administration (FDA), as well as receiving the European Community Ce mark of approval.

“We challenge ourselves to advance medical technology so that healthcare professionals and patients can benefit from innovative solutions that significantly improve outcomes and patient experience, while also creating a powerful economic model for our customers,” said Pete Valenti, division president of breast and skeletal health solutions at Hologic. “The launch of our Affirm prone biopsy system is the most significant advancement in prone biopsy technology since we introduced the first system more than 20 years ago.”

“Until now, we've been struggling to handle complex biopsies for subtle lesions or faint calcifications that we are only able to identify using 3D mammography exams,” said Alejandro Tejerina, MD of Centro Patologia de la Mama Fundación Tejerina (Madrid, Spain). “As an early testing site for the Affirm prone biopsy system, we've had the opportunity to perform many biopsies using this technology, and are pleased to report that this new biopsy table has helped to solve our challenges. We are able to visualize more tissue and have access to challenging lesion locations, and the procedures are very fast.”

Related Links:
Hologic

New
Mobile Cath Lab
Photon F65/F80
Portable Color Doppler Ultrasound Scanner
DCU10
Diagnostic Ultrasound System
MS1700C
Ultrasonic Pocket Doppler
SD1

Print article

Channels

MRI

view channel
Image: The AI tool can help interpret and assess how well treatments are working for MS patients (Photo courtesy of Shutterstock)

AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans

Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more